(PharmaNewsWire.Com, March 24, 2022 ) Chlorpheniramine Maleate Market size is estimated to reach $924 million by 2027, growing at a CAGR of 4.4% during the forecast period 2022-2027. Chlorpheniramine Maleate is an antiallergic medicine utilized in the treatment of different allergic conditions. It offers alleviation from runny nose, sneezing, itching, and watery eyes. Chlorphenamine (CP, CPM), also termed chlorpheniramine, is an antihistamine utilized to treat the symptoms of allergic conditions like allergic rhinitis (hay fever). It is consumed by mouth. The medicine takes impacts within 6 hours and lasts for around a day. Piriton tablets and syrup include the active ingredient chlorphenamine maleate. Investigations have indicated that the three medications fexofenadine, chlorpheniramine maleate, and Betamethasone have similar levels of efficiency in curbing the symptoms of allergic rhinitis. The physical signs have been found to be enhanced better with chlorpheniramine than the other two medications. Antihistamines are medications or other compounds that restrict the physiological impacts of histamine, utilized specifically in the treatment of allergies. Chlorpheniramine Maleate may be categorized under antihistamines. A dry mouth or xerostomia indicates a condition in which the salivary glands in the mouth do not prepare sufficient saliva to maintain the mouth wet. Xerostomia is one of the symptomatic unfavorable reactions generated by Chlorpheniramine maleate. The extensive application of ‘sedating antihistamine’ or anti-allergic termed Chlorpheniramine Maleate tablet to treat symptoms of allergies like itching nose/throat, runny nose, sneezing, or red/itchy/watery eyes is set to drive the Chlorpheniramine Maleate Market. The heightening pollution worldwide leading to allergies requiring increased application of antihistamines is set to propel the growth of the Chlorpheniramine Maleate Market during the forecast period 2022-2027. This represents the Chlorpheniramine Maleate Industry Outlook.
Chlorpheniramine Maleate Market Segment Analysis – By Product
The Chlorpheniramine Maleate Market based on the product can be further segmented into Injection, Syrup, Tablets, and Powder. The Injection Segment held the largest market share in 2021. This growth is owing to the growing application of Chlorpheniramine Injection in the treatment of allergic conditions. Chlorpheniramine 10 mg/ml Solution for Injection is available. The surging application of Chlorpheniramine Injection in the treatment of acute urticaria and hay fever is further propelling the growth of the Injection segment.
Furthermore, the Tablets segment is estimated to grow with the fastest CAGR of 4.8% during the forecast period 2022-2027 owing to the expanding application of Chlorpheniramine tablets for alleviation from symptoms of allergy-like sneezing, running nose, watery eyes, itching, swelling, and congestion or stiffness.
Chlorpheniramine Maleate Market Segment Analysis – By Application
The Chlorpheniramine Maleate Market based on the application can be further segmented into Allergy, Hay Fever, Common Cold, Watery Eyes, Itchy Throat/Skin, Anaphylactic Shock, Rhinitis and Urticaria. The Allergy Segment held the largest market share in 2021. This growth is owing to the surging application of Chlorpheniramine in the treatment of different allergic conditions. Chlorpheniramine performs by obstructing the activity of histamine and offers alleviation from symptoms like runny nose, sneezing, itching, skin rashes, and watery eyes. Chlorpheniramine, therefore, belongs to the group of antihistamines that provide relief from allergy and can be thus applied in the treatment of allergic patients which is further propelling the growth of this segment.
Furthermore, the Rhinitis segment is estimated to grow with the fastest CAGR of 5.0% during the forecast period 2022-2027 owing to the soaring application of Chlorpheniramine in the treatment of rhinitis and the great positive impact recorded and soaring average rating received from users of the medication.
Chlorpheniramine Maleate Market Segment Analysis – By Geography
The Chlorpheniramine Maleate Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Chlorpheniramine Maleate Market) held the largest share with 37% of the overall market in 2021. The growth of this region is owing to the increasing predominance of allergic reactions in the region resulting in the greater application of Chlorpheniramine. The presence of key players like Cardinal Health, Inc. in conjunction with the large patient pool seeking treatment is further propelling the growth of the Chlorpheniramine Maleate Market in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like accelerated urbanization increasing the environmental pollution in the region resulting in a greater count of cases with allergy requiring soaring application of Chlorpheniramine. The existence of a large population in countries like India is leading to bigger patient pools requiring treatment with Chlorpheniramine which is fuelling the progress of the Chlorpheniramine Maleate Market in the Asia-Pacific region.
Chlorpheniramine Maleate Market Drivers
Surging Application Of Chlorphenamine Is Projected To Drive The Growth Of Chlorpheniramine Maleate Market:
Chlorpheniramine maleate belongs to the category of first-generation antihistamines that are extensively to treat symptoms of allergic rhinitis and the common cold. Chlorpheniramine maleate seems to be an odor-free white crystalline solid or white powder with a pungent taste. Chlorphenamine is utilized to alleviate the symptoms of hay fever, rhinitis, urticaria, and asthma. Chlorpheniramine is a histamine-H1 receptor antagonist designated for the administration of symptoms related to upper respiratory allergies. It has also been utilized in veterinary uses. One of the most extensively utilized of the classical antihistamines, it typically brings about less drowsiness and sedation than promethazine. The heightening application of Chlorphenamine is therefore fuelling the growth of the Chlorpheniramine Maleate Market during the forecast period 2022-2027.
Technological Innovations Are Expected To Boost The Demand Of Chlorpheniramine Maleate:
Innovative applications involving Chlorpheniramine Maleate are likely to boost the growth of the Chlorpheniramine Maleate Market. Novel chlorpheniramine maleate (CPM) discriminatory electrochemical membranes were made by utilizing chlorpheniramine maleate-molecularly imprinted polymers. MIP was made by bulk polymerization utilizing 2-hydroxyethyl methacrylate (2-HEMA) as a monomer, ethylene glycol dimethacrylate (EGDMA) as a cross-linker, and benzoyl peroxide (BPO) as an initiator at 600C. Three CPM-MIP electrodes were built by utilizing tri-tolyl Phosphate (ToCP), tris (2- ethyl hexyl) Phosphate (TEHP), and tributyl phosphate (TBP) as plasticizers in the PVC matrix. Electrode parameters are inclusive of slopes, working concentrations ph. The interference impact in the existence of (Na+, Mg+2, Al+3, Glycine, Alanine, Arginine, and Phenylalanine) was investigated utilizing the segregated and mixed techniques to decide the selectivity coefficient determination. MIP is made by utilizing the identical composition of MIP molecularly imprinted polymer electrodes except for the template (CPM). The slopes of CMPMIP are 21.00, 21.50, and 19.08 mV/ decade, linearity range for the electrodes around. (10-5 10-1) M, the stable at a pH range from 4.0 to 8.5 and lifetime was from 30 to 10 days. The recommended electrodes were favorably used for the conclusion of CPM in certain pharmaceutical preparations, which were provided agreeable precision. These kinds of technological advancements are driving the growth of the Chlorpheniramine Maleate Market during the forecast period 2022-2027.
Limitations Of Applications Of Chlorpheniramine Present Challenges To The Growth Of The Chlorpheniramine Maleate Market:
Chlorpheniramine has side effects like sleepiness or abnormal drowsiness, blurred or double vision, dry mouth, or xerostomia with rare cases of serious jaundice and serious aplastic anemia. It is not recommended for application in patients with a recognized allergy to Chlorpheniramine. It is not recommended for application in children aged less than 2 years. Chlorpheniramine is not recommended for application in patients with benign prostatic hyperplasia (enlarged prostate) owing to the raised difficulty in passage of urine. Application of Chlorpheniramine is not suggested if the patient has consumed Monoamine Oxidase (MAO) inhibitors such as selegiline or rasagiline within the previous 14 days. Their integration may raise the hazard of adverse impacts such as drowsiness and blurred vision. These issues are hampering the growth of the Chlorpheniramine Maleate Market.
Chlorpheniramine Maleate Market Landscape
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Chlorpheniramine Maleate Market. Key companies of this market are:
Cardinal Health, Inc.
Sun Pharmaceutical Industry Limited
Johnson & Johnson
In November 2021, Cardinal Health declared its business, WaveMark™ Supply Management, and Workflow Solutions, which will presently be accessible for implementation in clinical laboratories across the U.S. The role clinical laboratories play in the continuity of care is crucial: 70% of medical decisions are taken with direction from a laboratory outcome. Even before the pandemic, however, the clinical lab workforce was constrained owing to both a retreating workforce within the laboratory and an elderly population that raised testing demand.
In October 2021, Cardinal Health developed an interactive instrument that offers pharmacists essential advice to assist them to navigate the current Food and Drug Administration (FDA) endorsement of the earliest interchangeable biologic authorized in the U.S. The FDA endorsement was provided to the long-acting insulin termed Semglee (insulin glargine-yfgn), which is presently indicated as a biosimilar for one of the most extensively utilized and expensive biologic treatments on the market currently – insulin. The novel instrument is planned to assist pharmacies to navigate state-by-state interchangeability laws for the FDA’s novel regulatory designation.
In April 2021, Cardinal Health introduced Outcomes™, a digital ecosystem linking pharmacists, payers, and pharmaceutical firms to lighten the challenges of non-obedience of medication. Outcomes transfer digital health solutions for personalized medication therapy administration, digital patient engagement, and tele-pharmacy, through its Connect™ platform. Therefore these three customer groups can enhance patient obedience to medication, fuel superior health outcomes for patients, and decrease the cost of care. Outcomes integrate numerous existing Cardinal Health businesses within Connected Care, inclusive of mscripts™, OutcomesMTM™, and TelePharm.
Geographically, North America Chlorpheniramine Maleate Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the expanding predominance of allergic reactions requiring usage of antihistamines and the enormous count of people looking for treatment in the North American region.
Chlorpheniramine Maleate Market growth is being driven by the surging application of Chlorpheniramine maleate is an alkylamine antihistamine utilized in the treatment of allergic conditions like rhinitis and urticaria. However, the dearth of awareness and side effects of Chlorpheniramine are some of the major factors hampering the growth of the Chlorpheniramine Maleate Market.
Chlorpheniramine Maleate Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Chlorpheniramine Maleate Market report.
For more Lifesciences and Healthcare Market reports, please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to firstname.lastname@example.org to discuss more about our consulting services.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: